Cellular therapies in Acute Lymphocytic Leukemia
From trials evaluating drugs to trials evaluating treatment algorithms – Focus on the SHIVA trial
Results of a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine vs Gemcitabine Alone for Patients With Metastatic Adenocarcinoma.
Results of a Randomized Phase III Trial (MPACT) of Weekly nab -Paclitaxel Plus
Predictive Biomarkers of EGFR Targeted Therapy: Beyond KRAS
